BRCA2COMPLEXES
Structural and biochemical characterization of the BRCA2 breast cancer tumour suppressor
| Coordinatore | CANCER RESEARCH UK
Organization address
address: ST JOHN STREET 407 ANGEL BUILDING contact info |
| Nazionalità Coordinatore | United Kingdom [UK] |
| Totale costo | 231˙283 € |
| EC contributo | 231˙283 € |
| Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | FP7-PEOPLE-2013-IEF |
| Funding Scheme | MC-IEF |
| Anno di inizio | 2014 |
| Periodo (anno-mese-giorno) | 2014-04-01 - 2016-03-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
CANCER RESEARCH UK
Organization address
address: ST JOHN STREET 407 ANGEL BUILDING contact info |
UK (LONDON) | coordinator | 231˙283.20 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'Our genetic material is constantly exposed to mutagenic factors. DNA double-strand breaks (DSBs) represent one of the most dangerous forms of DNA damage and cells utilise two major pathways for their repair: error-prone non-homologous end-joining (NHEJ) and error-free homologous recombination (HR). The breast cancer susceptibility protein BRCA2 is a central player in HR that cooperates with its partner PALB2 in promoting the recruitment of RAD51 recombinase to the site of DNA damage. BRCA2 function is essential for the maintenance of genome integrity and mutations in the BRCA2 gene have been linked to breast and ovarian cancer, and to the cancer-prone syndrome Fanconi anemia.
To obtain new insights into how various aspects of homology-directed repair are coordinated by BRCA2 and its cofactors I intend to:
1. Characterize the structural properties of BRCA2 together with its partners RAD51 and PALB2, in order to identify important interaction regions. 2. Define the functional relevance of these interaction sites using a combination of biochemical and in vivo techniques to uncover the molecular mechanism of BRCA2-mediated DNA repair and to address the specific roles of its partner proteins RAD51 and PALB2.
The results will be important for understanding the molecular basis of BRCA2-associated pathogenesis.'